Radcom Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $61M+18.2% YoYTTM through 31 Dec 2025
Net Income $12M+72.1% YoYTTM through 31 Dec 2025
Free Cash Flow $14.2MTTM through 31 Dec 2025
Margins
| Current | |
|---|---|
| Gross Margin | 76.0% |
| EBITDA Margin | 14.7% |
| Operating Margin | 11.6% |
| Net Margin | 19.7% |
Returns
10.5%ROE
8.3%ROA
14.3%ROIC
Balance Sheet Health
Debt / Equity0.00x
Current Ratio5.75x
Net Debt-$109.9Mnet cash position
Cash & Equivalents$30.5M
Quality Metrics
Altman Z-Score4.45
Piotroski F-Score7 / 9
FCF Margin23.3%
Rule of 4051.4
Earnings-Beat Rate100.0%
Multi-Year Trend
RevenueFY2025: $71.5M
Diluted EPS$0.71TTMFY2025: $0.71
Dividend
No dividend
Capital Allocation
R&D Spend$20.2M
Capex Intensity0.6%
Segment Performance
No segment data available.
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.